| |
| |
SPOT ON
|
| |
Orphan drug pirfenidone (ESBRIET): benefit legally enacted
Summary of product characteristics - updated at a snail´s pace
|
| |
| |
NEW ON THE MARKET
|
| |
Botulinum toxin type A (BOTOX) against chronic migraine |
| |
| |
a-t READER'S QUESTIONS AND COMMENTS
|
| |
Discount contracts: boon or bane?
Tamoxifen and CYP 2D6 testing: what´s new?
|
| |
| |
IN BRIEF
|
| |
Recourse due to fictitiously approved drugs
Pancreatitis - sitagliptin (JANUVIA, XELEVIA) safety study is overdue
Confirmed - ADHD more often diagnosed in the youngest children of a class
Association Voluntary Self-Regulation for the Pharmaceutical Industry (Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.) on "ordering" of samples via the courier
|
| |
| |
CURRENT ADR NETWORK REPORT
|
 |
Fatal rhabdomyolysis following isotretionin |
| |
| |
SIDE EFFECTS
|
| |
Severe allergy to mould fungus homeopathics
Severe hypersensitivity reaction against gout medication febuxostat (ADENURIC)
New contraindication for strontium ranelate (PROTELOS)
|
| |
| |
e a-t IN INTERNET
|
| |
Fictitiously approved drugs: information supplementing the in brief story
|
| |
